Investigating the role of LRRK2 and oxidative stress in Parkinson's disease
LRRK2 and oxidative stress in Parkinson’s disease
This study is looking at how a protein linked to Parkinson's disease gets activated by stress in cells and how this affects cell function, with the hope of finding new ways to help manage the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10795155 on NIH RePORTER |
What this research studies
This research focuses on understanding how LRRK2, a protein associated with Parkinson's disease, is activated by oxidative stress and its effects on cell function. The study will explore the mechanisms by which LRRK2 activity is stimulated and its relationship with mitochondrial dysfunction, which is known to contribute to Parkinson's disease. By examining the effects of various stressors on LRRK2, the research aims to uncover important insights into the disease's progression and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Parkinson's disease, particularly those with LRRK2 mutations or idiopathic forms of the disease.
Not a fit: Patients with Parkinson's disease caused by factors unrelated to LRRK2 or oxidative stress may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating or preventing Parkinson's disease by targeting LRRK2 activity.
How similar studies have performed: Previous research has shown promising results in understanding the role of oxidative stress in Parkinson's disease, making this approach both relevant and potentially impactful.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Greenamyre, J Timothy — University of Pittsburgh at Pittsburgh
- Study coordinator: Greenamyre, J Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.